MedTrace Logo

A Phase IV Study Investigating the Effects of Remifentanil Concentrations on Propofol Requirements for Loss of Consciousness, Response to Painful Stimuli, Bispectral Index and Associated Haemodynamic Changes

NCT02287181 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-03-11

No results posted yet for this study

Summary

A prospective, randomised, phase IV trial including 150 patients.

To evaluate the effects of varied concentrations of remifentanil on the proposal requirements for the loss of consciousness and response to pain and to evaluate the haemodynamic changes and processed EEG (BIS) during induction of anaesthesia.

Conditions

  • Induction of Anaesthesia

Interventions

DRUG

Remifentanil

short acting opiate

DRUG

Propofol

hypnotic drug

OTHER

Bispectral index

electroencephalograph

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Michael Irwin, MbChB · Hong Kong University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02287181 on ClinicalTrials.gov